PubMed Health⌕ Search

Biomedical subjects

E Wróblewska

Publications and source records attributed to E Wróblewska.

11 recordsLinked to original sources
PubMed2001

[Treatment of eyelid hemangioma in children with intralesional steroid injection].

Infantile hemangiomas affect about 5% (3-10%) of the population, showing a predilection for the face. Infants with hemangiomas of the eyelid are at risk amblyopia and strabismus. This is also a cosmetic defect. Several methods of treating these tumors have been associated with many complications. The use of intralesional steroid injections seems to be a simple, safe and effective method of treating hemangiomas of the eyelid in children.

Adolescent↗
PubMed2000

[Amoeba of the Acanthamoeba species in swimming pools and lakes of the Lublin area and in people using contact lenses].

Examinations of water for the presence of Acanthamoeba in covered and open air swimming pools and lakes of the city of Lublin were performed in order to determine the places where the invasion of amoebas of Acanthamoeba kind on the eyes can occur. Pathogenic strains of Acanthamoeba were found in all collected water samples. The cultures from the conjunctival sac of regular swimmers practising every day in these pools were taken. Amoebas were found in none of the examined cultures. The observations have shown that contact lenses should be protected from the contamination with swimming pool water. Amoebas were not revealed in the conjunctival sac of the swimmers after bathing.

Adult↗
PubMed1999

[Squamous metaplasia of bulbar conjunctiva in the course of long-term topical antiglaucoma therapy].

PURPOSE: The aim of this study was to determine how long-term topical antiglaucoma treatment affects the bulbar conjunctiva. MATERIAL AND METHODS: 59 glaucoma patients and 30 healthy people were examined by the use of impression cytology for changes in bulbar conjunctiva. Patients with glaucoma were on stable regimen of one or two antiglaucoma drugs for a minimum 1 year. RESULTS: Squamous metaplasia of bulbar conjunctiva was found in 26.6% of patients treated with beta-blocker alone for 1-2 years and in 42.8% of patients treated with this drug for longer than 2 years. Similar changes were found in patients treated with beta-blocker with miotic--in 60% people who were on stable regimen for 1-2 years and in 70% treated longer than 2 years. No conjunctival changes were observed in healthy people. CONCLUSIONS: Long-term topical antiglaucoma medication may produce squamous metaplasia of bulbar conjunctiva.

Administration, Topical↗
PubMed1999

[Goblet cells density of bulbar conjunctiva after long-term topical antiglaucoma agents].

AIM: The purpose of this study was to determine the effect of long-term topical antiglaucoma therapy on goblet cells density of the bulbar conjunctiva. MATERIAL AND METHODS: Conjunctiva impression cytology specimens from 59 glaucoma patients and 30 healthy people were assessed quantitatively by light microscopy. Patients with glaucoma were on a stable regimen of one (beta-blocker alone) or two (beta-blocker with miotic) topically administered medications for a minimum 1-year. RESULTS: The results show statistically significant decrease in goblet cells associated with number of antiglaucoma drugs and duration of treatment. CONCLUSIONS: Long-term topical antiglaucoma treatment decrease goblet cells population of bulbar conjunctiva.

Adrenergic beta-Antagonists↗
PubMed1999

[Schirmer test I and BUT (break-up-time) in patients treated with topical antiglaucoma drugs for a long time].

PURPOSE: The aim of this study was to evaluate Schirmer test I and BUT in patients after long-term topical antiglaucoma medication. MATERIAL AND METHODS: 59 glaucoma patients on stable regimen of one or two antiglaucoma drugs (for a minimum 1 year) and 30 healthy people were checked for changes of the precorneal tear film. Tear secretion was measured by Schirmer test I and stabilization of precorneal film by break-up time. RESULTS: We found no influence of antiglaucoma drugs on tear secretion. Statistically significant decrease in break-up time was found in glaucoma patients. CONCLUSIONS: Long-term topical antiglaucoma medication may alter precorneal film stabilization.

Adolescent↗
PubMed1994

[Treatment of idiopathic blepharospasm with botulinum toxin A].

The preparations of botulinum toxin A--Botox and Porton were injected into the orbicular muscle of eye in 18 patients with idiopathic blepharospasm or Meige's syndrome. Improvement was achieved in 17 patients; in 10 injections should be repeated after about 8 weeks. Minor side effects declined after several days. Injection of botulinum toxin could be effective in this disease, otherwise hard to cure.

Aged↗
PubMed1993

[Treatment of orbital hemangioma].

Hemangiomas occur in 1%-2.6% of newborn infants and, after 7 years, they disappear in 70% of them. Indications for the treatment are the deterioration of visual function and great cosmetic defects. Both surgical and radiological therapy are likely to cause numerous complications. The reports concerning the beneficial effect of corticosteroids, injected directly into hemangiomas, have recently been presented. In two of our patients, aged 32 and 43, the injection of steroids resulted in the disappearance of hemangioma during 2-4 weeks.

Adult↗